This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Jessica Zelinski
Senior Engineer, Process Development at Eli Lilly and Company
Speaker

Profile

Jessica Zelinski is a process development engineer in the Synthetic Molecule Design and Development organization at Eli Lilly. She studied Chemical and Biomolecular Engineering at the University of Notre Dame and joined Lilly’s Oligonucleotide Capability Team in 2021. Jessica has received Lilly’s Outstanding Engineering Contribution Award for her work on the novel fluidized bed oligonucleotide synthesizer platform, as well as Health, Safety, and the Environment and LRL President’s Awards for the team’s efforts in reducing solvent consumption.

Agenda Sessions

  • Fluidized Bed Reactor Strategy to Solid Phase Synthesis from Regulatory Perspective

    09:05